As financial and supply chain pressures mount, healthcare organizations are taking a more collaborative approach to capital procurement and supplier partnerships.
As healthcare organizations navigate rising costs, inflation and continued tariff uncertainty, capital equipment decisions are facing greater scrutiny. The traditional focus on upfront price is giving way to a broader evaluation of total cost of ownership, utilization, interoperability, service requirements and long-term value. At the same time, lessons from the pandemic have reinforced the importance of supply chain resilience, while sustainability and cross-functional collaboration are becoming increasingly important considerations.
In the following interview with Repertoire, Bill Muich, Senior Director, Equipment Sales & Service, Concordance Healthcare Solutions, discusses how these trends are reshaping capital equipment procurement. He also shares his perspective on evaluating technology based on measurable outcomes, balancing innovation with practical business needs, and building supplier relationships that extend beyond the transaction.
Rising costs, inflation and tariffs continue to pressure healthcare organizations. How are these forces changing the way health systems think about procurement decisions?
Bill Muich: Healthcare organizations are under more pressure than ever to maximize every dollar they spend. Rising costs, inflation and tariffs have made it clear that procurement can no longer be viewed as a transactional function, it must be a strategic one. At Concordance, we are seeing health systems place greater emphasis on total cost of ownership, standardization and utilization data rather than focusing solely on purchase price. Leaders are looking for partners who can provide market intelligence, identify cost-saving opportunities and help them make decisions that balance financial stewardship with high-quality patient care.
How has the capital equipment procurement process changed compared with 5 or 10 years ago?
Muich: Capital procurement has become much more collaborative and data driven. Five or 10 years ago, purchasing decisions were often led by individual departments or clinicians. Today, organizations are bringing together clinical, financial, operational and supply chain stakeholders much earlier in the process. They are asking tougher questions about utilization, long-term maintenance costs, interoperability and return on investment. IT is often actively involved with medical diagnostic equipment decisions to make sure the new equipment interfaces with their EMR. Concordance supports this evolution by helping customers evaluate capital purchases through a comprehensive lens that aligns equipment decisions with broader organizational goals.
How should organizations evaluate whether a capital investment is truly creating value versus simply adding another technology or piece of equipment?
Muich: Value should be measured by outcomes, not by the technology itself. Before making an investment, organizations should define the clinical, operational and financial objectives they expect the equipment to achieve. That includes improvements in patient outcomes, workflow efficiency, staff productivity, service line growth and overall cost of care. At Concordance, we encourage customers to establish measurable success criteria before making a purchase and use data to evaluate performance after implementation. Technology should solve a clearly identified problem – not simply represent the latest innovation.
How do organizations avoid adopting technology simply because it is new, rather than because it solves a meaningful business problem?
Muich: Innovation should always begin with identifying a need. Organizations that are most successful start by asking what challenge they are trying to solve rather than what new technology is available. A disciplined evaluation process includes input from clinicians, supply chain leaders, finance and operations, along with an assessment of workflow impact, implementation requirements and measurable outcomes. Concordance helps customers focus on solutions that deliver meaningful value and support their strategic priorities instead of chasing technology for technology’s sake.
The pandemic changed how organizations think about supply chain risk. What lessons from that period are still shaping decisions today?
Muich: The pandemic reinforced that supply chain resilience is essential to patient care. Organizations recognize the importance of supplier diversification, inventory visibility and proactive planning rather than reacting to disruptions after they occur. Health systems are also placing greater value on trusted distribution partners that can provide transparency, communication and strategic guidance during periods of uncertainty. They are looking at where the piece of equipment is manufactured and if the parts are readily available. At Concordance, those lessons continue to shape how we help customers strengthen supply continuity while maintaining operational efficiency.
Sustainability is increasingly part of procurement conversations. How are environmental considerations influencing healthcare purchasing decisions?
Muich: Sustainability has become an important factor alongside cost, quality and clinical performance. Healthcare organizations are evaluating suppliers based on packaging reduction, waste management, product lifecycle, transportation efficiency and broader environmental initiatives. They are also looking for opportunities where sustainability and financial performance align, such as reducing unnecessary inventory, minimizing product waste and improving operational efficiency. Concordance works with manufacturers and providers to identify practical sustainability opportunities that support both environmental goals and responsible resource management.
What separates a transactional supplier relationship from a true supply chain partnership?
Muich: A transactional supplier delivers products. A true supply chain partner delivers expertise, insight and long-term value. At Concordance, partnership means understanding each organization’s unique challenges, collaborating on strategic goals and bringing data-driven recommendations that improve performance over time. It involves transparency, accountability, proactive communication and a shared commitment to better patient care. We collaborate with all parties in a healthcare setting from clinicians, finance, IT and many more departments to ensure critical input is garnered and that the equipment purchased satisfies the need not only today but for the future. The strongest partnerships are built on trust and a mutual focus on helping healthcare organizations achieve measurable clinical, operational and financial outcomes.
Bill Muich is a healthcare sales and business development executive with more than three decades of experience in medical equipment, supply chain solutions and healthcare distribution. As Senior Director of Equipment Sales and Service at Concordance Healthcare Solutions, he leads national growth initiatives and strategic partnerships that support healthcare providers across the United States.
Key Takeaways
- Rising costs, inflation and tariffs are pushing health systems to evaluate capital purchases based on total cost of ownership, utilization and long-term value rather than purchase price alone.
- Capital equipment decisions are becoming more collaborative and data driven, bringing clinical, financial, operational, supply chain and IT stakeholders into the process earlier.
- Organizations should define measurable clinical, operational and financial objectives before investing in technology and evaluate whether the equipment actually delivers those outcomes.
- Supply chain resilience, sustainability and trusted supplier partnerships are increasingly important considerations in equipment procurement and long-term value creation.